A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 45/06 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2534271
Pharmaceutical compositions are disclosed for the treatment of obesity, an overweight condition and compulsive overeating. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotinic receptor partial agonist and an alpha2dela ligand and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.
Compositions pharmaceutiques destinées au traitement de l'obésité, de la surcharge pondérale et de la frénésie alimentaire. Ces compositions pharmaceutiques sont constituées par une association efficace sur le plan thérapeutique d'un agoniste partiel des récepteurs nicotiniques et d'un ligand alpha2delta, ainsi que par un excipient pharmaceutiquement acceptable. On a également prévu un procédé de mise en oeuvre de composé de ce type.
Coe Jotham Wadsworth
O'neill Brian Thomas
Sands Steven Bradley
Pfizer Products Inc.
Smart & Biggar
LandOfFree
A pharmaceutical composition for the treatment of obesity or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A pharmaceutical composition for the treatment of obesity or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A pharmaceutical composition for the treatment of obesity or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1633803